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Abstract
Background: Biofilms are ubiquitous. For instance, the majority of medical infections are thought to involve biofilms. 
However even after decades of investigation, the in vivo efficacy of many antimicrobial strategies is still debated 
suggesting there is a need for better understanding of biofilm antimicrobial tolerances. The current study's goal is to 
characterize the robustness of biofilm antibiotic tolerance to medically and industrially relevant culturing 
perturbations. By definition, robust systems will return similar, predictable responses when perturbed while non-robust 
systems will return very different and potentially unpredictable responses. The predictability of an antibiotic tolerance 
response is essential to developing, testing, and employing antimicrobial strategies.
Results: The antibiotic tolerance of Escherichia coli colony biofilms was tested against beta-lactam and aminoglycoside 
class antibiotics. Control scenario tolerances were compared to tolerances under culturing perturbations including 1) 
different nutritional environments 2) different temperatures 3) interruption of cellular quorum sensing and 4) different 
biofilm culture ages. Here, antibiotic tolerance was defined in terms of culturable biofilm cells recovered after a twenty 
four hour antibiotic treatment.
Colony biofilm antibiotic tolerances were not robust to perturbations. Altering basic culturing parameters like 
nutritional environment or temperature resulted in very different, non-intuitive antibiotic tolerance responses. Some 
minor perturbations like increasing the glucose concentration from 0.1 to 1 g/L caused a ten million fold difference in 
culturable cells over a twenty four hour antibiotic treatment.
Conclusions: The current study presents a basis for robustness analysis of biofilm antibiotic tolerance. Biofilm 
antibiotic tolerance can vary in unpredictable manners based on modest changes in culturing conditions. Common 
antimicrobial testing methods, which only consider a single culturing condition, are not desirable since slight culturing 
variations can lead to very different outcomes. The presented data suggest it is essential to test antimicrobial strategies 
over a range of culturing perturbations relevant to the targeted application. In addition, the highly dynamic antibiotic 
tolerance responses observed here may explain why some current antimicrobial strategies occasionally fail.
Background
Biofilms plague both medical and industrial surfaces and
are difficult to treat with common antimicrobial strate-
gies [1,2]. Cells residing within biofilms are often tolerant
to antimicrobial agents at concentrations thousands of
times higher than what is necessary to eradicate the same
cells growing planktonicly (e.g. [3,4]). This recalcitrance is
likely due to a combination of physical and physiological
factors. Cells from a disrupted biofilm typically become
susceptible to antibiotics when regrown planktonicly [5-
7].
The ubiquity of biofilms and their associated financial
costs have inspired intensive antifouling efforts. A widely
used anti-biofilm approach is to impregnate surfaces with
antiseptics or antibiotics (reviewed in [8,9]). The benefit
of antimicrobial impregnated medical devices is still con-
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troversial despite decades of research and investment. For
example, after reviewing years of studies, McConnell et
al. [10,11] conclude that more rigorous investigations are
required to either support or refute the hypothesis that
central venous catheters coated with antimicrobial agents
reduce the rate of blood stream infections. While other
researchers disagree with these conclusions (e.g. [12]), the
fact there is still a debate regarding the efficacy of these
strategies suggests there is need for better technologies
and a better understanding of what parameters influence
bacterial tolerance to antimicrobial agents.
The current study aims to characterize colony biofilm
antibiotic tolerance as a function of culturing conditions.
The colony biofilm model is a widely adopted culturing
system which possesses most features included in the
numerous attempts to define a biofilm including: high cell
density, extracellular polymeric substance, chemical gra-
dients, spatially dependent microbial activities including
slow growth, and reduced susceptibility to antibiotics (e.g.
[4,13-16]). This study utilizes an engineering approach,
known as robustness analysis, which is used to analyze
complex systems. Robustness analysis determines the sta-
bility of a system response to perturbations. Robust sys-
tems return similar or identical responses when
perturbed while non-robust systems return very different
responses [17,18]. Biofilm antibiotic tolerance is a prod-
uct of complex cellular systems. The presented study
examines the robustness of colony biofilm antibiotic tol-
erance to industrially and medically relevant perturba-
tions including 1) nutrient environment 2) temperature
3) quorum sensing ability and 4) growth phase.
To our knowledge, this is the first time robustness anal-
ysis has been applied to biofilm antibiotic tolerance. Anti-
biotic tolerance is at the heart of many practical
challenges related to unwanted biofilms. Being able to
predict biofilm antibiotic tolerance as a function of cul-
turing perturbations is essential for rationally designing
and evaluating antimicrobial strategies. The presented
results shed insight on the varying success rates of com-
mon anti-fouling strategies like antibiotic impregnated
coatings and provide a template for improved antimicro-
bial testing schemes.
Results
1. Antibiotic tolerance in planktonic and biofilm cultures
Biofilms often exhibit very different antibiotic tolerances
than planktonic cultures [1-4]. To interpret the presented
biofilm data in an appropriate context, the antibiotic tol-
erances of biofilm cultures were compared to planktonic
cultures. Antibiotics representing the aminoglycoside
and beta-lactam classes were used as proxies for the
diverse array of utilized agents.
Kanamycin and ampicillin tolerances were determined
for planktonic and biofilm cultures grown in Luria-Ber-
tani (LB) medium at 37°C. These antibiotics were highly
effective against planktonic cultures reducing colony
forming units (cfu's)/ml by 6 to 9 orders of magnitude
(Fig. 1a). The biofilm antibiotic tolerance results were
varied. Kanamycin produced a 9 log10 reduction in cfu's
per biofilm while ampicillin resulted in only a one log10
reduction in cfu's per biofilm (Fig 1b). Subsequent biofilm
responses to culturing perturbations were compared to
these base tolerance results (Fig. 1b). Just prior to antibi-
otic challenge, the biofilm cultures contained 9.3 log10 ±
0.1 cfu's/biofilm while the planktonic cultures had 7.8 ±
0.2 log10 cfu's/ml. Additional data illustrating differences
in colony biofilm antibiotic susceptibility as compared to
planktonic cultures can be found in Additional file 1, Figs.
S1 and S5.
The results reinforce the concept that biofilm cultures
can behave very differently from planktonic cultures and
trends from planktonic cultures may not be relevant to
biofilm cultures. Considering the well established impor-
tance of biofilms in medical infections, it is essential to
test antimicrobial strategies against relevant microbe
growth conditions.
2. Nutritional perturbations
Surfaces susceptible to microbial colonization are often
subjected to changing nutrient levels. For instance, a cen-
tral venous catheter would experience different blood
glucose levels based on patient activity, diel feeding
schedules, or medical conditions like diabetes. Industrial
food preparation surfaces could experience different
nutrient loads based on worker schedules. The effect of
nutritional environment perturbations on biofilm antibi-
Figure 1 Comparison of planktonic and biofilm antibiotic toler-
ance. Wild-type E. coli K-12 cultures were grown on LB only medium at 
37°C. Cultures were grown for 6 hours before being transferred to fresh 
antibiotic treatment medium for 24 hours. Reported cfu/ml and cfu/
biofilm data was determined after treatment. Black bars = control, dark 
gray bars = kanamycin (100 ug/ml), light gray bars = ampicillin (100 ug/
ml) challenge. Number at the base of each bar denotes the number of 
independent replicates. cfu = colony forming unit.Zuroff et al. BMC Microbiology 2010, 10:185
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otic tolerance was assayed to determine if antibiotic effi-
cacy would be predictable.
Perturbing the nutritional environment by adding 10 g/
L glucose to LB medium produced a large change in col-
ony biofilm kanamycin and ampicillin tolerance (Fig. 2).
In the presence of glucose, kanamycin reduced cfu's per
biofilm by approximately one order of magnitude. This is
in stark contrast with the 9 log10 decrease observed in the
absence of glucose. In the presence of glucose, ampicillin
produced a 7 log10 decrease in cfu's per biofilm. For com-
parison, ampicillin produced a one order of magnitude
reduction in cfu's per biofilm when grown on LB only.
Just prior to antibiotic challenge, the biofilm cultures
grown on LB + glucose contained 8.9 ± 0.1 log10 cfu's/bio-
film while the LB only cultures contained 9.3 ± 0.1 cfu's/
biofilm. Changes in antibiotic tolerance were not likely
due to different cell densities as reported with planktonic
S. aureus cultures [19]. Interestingly, perturbing plank-
tonic cultures with 10 g/L glucose had no statistically sig-
nificant effect on kanamycin and ampicillin tolerance
(Additional file 1, Fig. S1). The planktonic culture densi-
ties just prior to antibiotic challenge were 7.5 ± 0.4 log10
and 7.8 ± 0.2 log10 cfu/ml for the LB + glucose and LB
only cultures respectively.
The glucose effect was analyzed to determine what
magnitude of perturbation was required to elicit the
observed antibiotic tolerance changes. Five glucose
concentrations were tested (Fig. 3). The biofilm cul-
tures showed an increased sensitivity to ampicillin
when the initial glucose concentration was at least 1 g/
L. The shift in kanamycin tolerance was observed
between initial glucose concentrations of 1 and 5 g/L.
It should be noted that LB media contains trace con-
centrations of sugar but the quantities are not signifi-
cant enough to support measurable growth in
respiration negative E. coli [20].
The effect of glucose on antibiotic tolerance was
expanded to test other common hexoses found in the
human diet including the glucose isomer fructose, the
more reduced sorbitol, and the more oxidized gluconate.
All tested hexoses had effects analogous to glucose and
made the biofilm cultures more susceptible to ampicillin
(Fig. 4). Experiments also examined media augmented
with the carbohydrate glycerol or the organic acid suc-
cinic acid. The presence of glycerol produced an ampicil-
lin tolerance response similar to the hexose grown
cultures and a kanamycin response similar to the LB only
cultures. Cultures grown on succinic acid supplemented
medium had antibiotic tolerances analogous to the LB
only cultures.
E. coli strains unable to utilize glucose were constructed
by sequential deletion of the ptsG,  ptsM,  glk, and gcd
genes using the KEIO gene knock-out library and P1
transduction methods (see materials and methods). The
glucose negative cultures did not respond to glucose per-
turbations; antibiotic tolerance did not change signifi-
cantly between the presence and absence of glucose (Fig.
5). The glucose effect appeared to be a result of metabolic
adjustments, not membrane effects or the presence of an
inhibitory compound.
Figure 2 Effect of glucose perturbation on wild-type E. coli K-12 
biofilm antibiotic tolerance. Cultures were grown as biofilms for 6 
hours before being transferred to antibiotic treatment plates for 24 
hours. Conditions included only LB medium and LB medium supple-
mented with 10 g/L of glucose. Reported cfu/biofilm data was deter-
mined after treatment. Black bars = control, dark gray bars = 
kanamycin (100 ug/ml), light gray bars = ampicillin (100 ug/ml) chal-
lenge. Number at the base of each bar denotes the number of inde-
pendent replicates. cfu = colony forming unit.
Figure 3 Effect of glucose concentration on antibiotic tolerance 
of wild-type E. coli K-12 biofilm cultures. Cultures were grown as 
biofilms for 6 hours before being transferred to antibiotic treatment 
plates for 24 hours. LB medium was supplemented with varying 
amounts of glucose indicated below each bar ranging from 0-10 g/L. 
Reported cfu/biofilm data was determined after treatment. Black bars 
= control, light gray bars = ampicillin (100 ug/ml) challenge. Number 
at the base of each bar denotes the number of independent replicates. 
cfu = colony forming unit.Zuroff et al. BMC Microbiology 2010, 10:185
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The biofilm cultures demonstrated a non-robust antibi-
otic tolerance response when the nutritional environment
was perturbed with carbohydrates. The data suggests that
appropriate nutrient concentration ranges must be con-
sidered when evaluating antimicrobial strategies.
3. Temperature perturbations
Surfaces susceptible to biofilm formation are often sub-
jected to temperature changes or gradients. For instance,
a central venous catheter would experience core body
temperature at the tip and room temperature at the bung.
A continuous gradient would exist between these two
extremes. This section's goal was to determine if the effi-
cacy of an antibiotic would be predictable when the sys-
tem temperature was perturbed.
Biofilm antibiotic tolerance was tested at temperatures
above and below the human core temperature of 37°C,
both in the presence and absence of glucose. The temper-
ature range was selected to consider room temperature
(21°C) relevant to many food items, industrial settings,
and the external surfaces of implanted medical devices
like catheters. The temperature of 42°C was selected to
represent the elevated temperatures associated with
pyrexia.
Antibiotic tolerance changed with some temperature
perturbations. At 21°C, kanamycin and ampicillin
reduced cfu's/biofilm by 6 to 9 orders of magnitude (Fig.
6a). This response was not affected by the presence of
glucose. At 42°C, biofilm antibiotic tolerance was analo-
gous to the results from 37°C; the cultures demonstrated
a large change in kanamycin and ampicillin tolerance as a
function of nutritional environment (Fig. 6b, c).
The biofilm antibiotic tolerance response is not robust
to perturbations in temperature. Changes in antibiotic
tolerance are not necessarily predictable a priori. In addi-
tion to considering nutrient environment, this data sug-
gests it is critical to know if an antibiotic treatment will be
effective over a device's operational temperature range.
4. AI-2 quorum sensing perturbations
Bacteria can communicate with other organisms and can
sense properties related to their surroundings using small
soluble molecules in a process termed quorum sensing
Figure 4 Effect of nutritional environment on antibiotic tolerance 
of wild-type E. coli biofilm cultures. Cells were grown as biofilms for 
6 hours before being transferred to treatment plates for 24 hours. All 
cultures were grown at 37°C in LB medium with or without an addi-
tional carbon source. All carbon source supplements were added at 10 
g/L, the succinic acid solution was pH adjusted to 6.8 before being 
added to medium. Reported cfu/biofilm data was determined after 
treatment. Black bars = control, dark gray bars = kanamycin (100 ug/
ml) challenge, light gray bars = ampicillin (100 ug/ml) challenge. Num-
ber at the base of each bar denotes the number of independent repli-
cates. cfu = colony forming unit.
Figure 5 Effect of glucose perturbation on E. coli K-12 biofilm cul-
ture antibiotic tolerance for wild-type and glucose negative mu-
tants. Cultures were grown as biofilms for 6 hours before being 
transferred to antibiotic treatment plates for 24 hours. Conditions in-
cluded only LB medium and LB medium supplemented with 10 g/L of 
glucose. Reported cfu/biofilm data was determined after treatment. 
Δglc- glucose negative E. coli K-12 strain (ΔptsG, ΔptsM, Δglk, Δgcd). 
Black bars = control, dark gray bars = kanamycin (100 ug/ml), light gray 
bars = ampicillin (100 ug/ml) challenge. Number at the base of each 
bar denotes the number of independent replicates. cfu = colony form-
ing unit.
Figure 6 E. coli biofilm antibiotic tolerance as a function of tem-
perature (21, 37, 42°C). Cells were grown as biofilms for 6 hours be-
fore being transferred to treatment plates for 24 hours. Reported cfu/
biofilm data was determined after treatment. a) Cultures grown at 
21°C, b) cultures grown at 37°C, and c) cultures grown at 42°C. Black 
bars = control, dark gray bars = kanamycin (100 ug/ml) challenge, light 
gray bars = ampicillin (100 ug/ml) challenge. Number at the base of 
each bar denotes the number of independent replicates. cfu = colony 
forming unit.Zuroff et al. BMC Microbiology 2010, 10:185
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(QS). QS has been associated with the multicellular coor-
dination of many microbial behaviors including pathoge-
nicity and biofilm formation (reviewed in e.g. [21,22]).
Combining QS interference strategies with antibiotic
treatments has been effective against certain microbes
under certain conditions and has generated considerable
scientific interest (e.g.[23], reviewed in [24]). The efficacy
of such combined treatments under perturbed culturing
conditions therefore represents a critical assessment of
the general applicability of the strategy.
A set of E. coli AI-2 QS gene deletion mutants was con-
structed to act as proxies for QS interference strategies
targeting different aspects of AI-2 QS. The strains lacked
key enzymes in AI-2 synthesis (ΔluxS), phosphorylation
(ΔlsrK), regulation (ΔlsrR), and degradation pathways
(ΔlsrF) (reviewed in [25]). The AI-2 system was chosen
because of its wide distribution among both Gram nega-
tive and positive organisms and because it has been
shown to modulate biofilm formation [25].
The E. coli K-12 MG1655 AI-2 QS mutants were con-
structed using the KEIO gene knock-out library and P1
transduction methods (see materials and methods). The
strains were characterized for planktonic and biofilm
growth characteristics. Mutant and wild-type planktonic
growth rates were nearly identical (Additional file1, Fig.
S2). Colony biofilm growth rates and final cell densities
also showed no statistical difference (Additional file1, Fig.
S3). The AI-2 production profiles for planktonic cultures
can be found in Additional file 1, Fig. S4. The AI-2 pro-
files were similar to previous reports [26-28].
Perturbation of AI-2 QS did not result in any significant
changes in biofilm antibiotic tolerance when cultured at
37°C on LB only medium (Fig. 7a). When the AI-2 QS
deletion mutants were perturbed with glucose, non-intui-
tive changes in antibiotic tolerance were observed. Delet-
ing genes associated with AI-2 synthesis (ΔluxS),
regulation (ΔlsrR), or degradation (Δlsrf) increased ampi-
cillin antibiotic tolerance. These cultures had 6 orders of
magnitude more cfu's/biofilm after ampicillin treatment
as compared to both wild-type and AI-2 phosphorylation
(ΔlsrK) mutants. Additional experimental data regarding
the effects of AI-2 gene deletions on antibiotic tolerance
can be found in Additional file 1, Figs. S5-S9. Interest-
ingly, the ΔluxS mutant demonstrated an altered glucose
catabolite repression response.
The results suggest E. coli biofilm antibiotic tolerance is
robust to perturbations in AI-2 QS when grown on LB at
37°C however; the response becomes non-robust in the
presence of glucose. The results indicate that QS interfer-
ence can have unpredictable results that change as a func-
tion of targeted gene and culturing perturbations.
5. Colony biofilm antibiotic tolerance and culture stage
The data presented in Figs. 1, 2, 3, 4, 5, 6 and 7 were col-
lected from biofilm cultures grown for 6 hours prior to
the 24 hour antibiotic challenge. At 6 hours, the biofilm
cultures were still growing (Additional file 1, Fig. S3).
Additional experiments examined antibiotic tolerance
when the biofilm cultures were grown for 12 or 24 hours
prior to antibiotic challenge. At these time intervals, the
cultures would be in early and established stationary
phase (Fig. S3).
When grown on LB only, there was a growth stage
dependent change in antibiotic tolerance. For instance,
cultures grown for 12 hours prior to ampicillin challenge
had 7 orders of magnitude more culturable cells per bio-
film than cultures grown for 6 hours prior to challenge
(Fig. 8a). When cultures were grown on LB + glucose, no
significant, culturing phase dependent kanamycin toler-
ance effect was observed (Fig. 8b). The biofilm cultures
grown in the presence of glucose did show a culturing
stage dependent tolerance to ampicillin. A 6 log10 differ-
ence in cfu's per biofilm was observed between the sam-
ples grown for 6 and 12 hours prior to antibiotic
challenge.
Colony biofilms exhibited a non-robust antibiotic toler-
ance as a function of growth stage. This was anticipated.
Antibiotics are generally more effective against dividing
cells than stationary phase cells. Therefore, the lack of a
growth stage dependent kanamycin tolerance in the pres-
ence of glucose was surprising. Depending on the specific
Figure 7 Effect of AI-2 quorum sensing circuit gene deletions on 
antibiotic tolerance of E. coli biofilm cultures. Cells were grown as 
biofilms for 6 hours before being transferred to treatment plates for 24 
hours. Reported cfu/biofilm data was determined after treatment. 7a) 
Cultures grown at 37°C on LB only medium. 7b) Cultures grown at 37°C 
on LB and 10 g/L glucose. ΔluxS mutant lacked gene for AI-2 synthesis, 
ΔlsrK mutant lacked gene for AI-2 phosphorylation, ΔlsrR mutant 
lacked gene for lsr operon repression, and ΔlsrF mutant lacked gene for 
AI-2 degradation. Black bars = control, dark gray bars = kanamycin (100 
ug/ml) challenge, light gray bars = ampicillin (100 ug/ml) challenge. 
Number at the base of each bar denotes the number of independent 
replicates. cfu = colony forming unit.Zuroff et al. BMC Microbiology 2010, 10:185
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antibiotic and the specific culturing condition, the effect
of growth stage on antibiotic tolerance may not be pre-
dictable. The results once again highlight the necessity of
appropriate growth conditions when testing anti-biofilm
strategies.
Discussion
The current study examined the robustness of colony bio-
film antibiotic tolerance as a function of culturing pertur-
bations.  E. coli antibiotic tolerance was not robust.
Perturbations in nutritional environment, temperature,
AI-2 QS ability, and biofilm age resulted in very different,
context specific, responses. Relatively small perturbations
like increasing the initial glucose concentration from 0.1
to 1 g/L, resulted in a 7 log10 difference in culturable cells
per biofilm after ampicillin challenge. Human blood glu-
cose levels average approximately 1 g/L. Changes in blood
glucose levels due to diel cycles, fasting, or diabetes could
significantly change a biofilm's susceptibility to antibiotic
treatments. A summary of the tolerance responses can be
found in Table 1. To facilitate cross experiment compari-
sons, the log reduction (LR) in cfu's/biofilm between con-
trol and challenged cultures was determined. The
difference between the smallest LR and the largest LR for
a set of culturing conditions was determined for 1) LB
+glucose vs. LB only, 2) culturing at 37°C vs. 21 and 42°C,
3) wild-type cultures vs. AI-2 QS deletion mutants as well
as for the aggregate perturbations 4) glucose and temper-
ature and 5) glucose and AI-2 QS mutants. The only per-
turbation to elicit a robust response for both kanamycin
and ampicillin was AI-2 QS interference. However, this
response was not robust when multiple perturbations
were considered. Aggregate perturbations always resulted
in a larger ΔLR indicating a less robust response. Taken
together, the data in Table 1 demonstrate that antibiotic
tolerance is highly susceptible to perturbations.
This study examined antibiotic tolerance in the model
organism E. coli. While this organism was selected for its
extensive literature base and its convenient molecular
biology systems, some E. coli strains are serious patho-
gens. For instance, there are uropathogenic strains associ-
ated with recurrent bladder and kidney infections,
adherent-invasive strains associated with Crohn's disease
[29], and diarrhoeagenic strains which are responsible for
an estimated 2 × 105 to 2 × 106 deaths per year [30]. The
lack of a robust antimicrobial tolerance response
observed with this model organism is likely relevant to a
wide range of enterobacter as well as other microorgan-
isms. This study examined the no shear colony biofilm
system. Other biofilm culturing systems which apply dif-
ferent levels of shear or use different substratum may
influence antibiotic susceptibility as suggested in [31].
Antibiotic tolerance is a complex emergent property of
numerous cellular systems. The observed changes in anti-
biotic tolerance are likely the result of numerous cellular
mechanisms. Nutritional environment had a large effect
on observed antibiotic tolerance. The role of carbon
source and anaerobiosis on antibiotic tolerance has been
reported for decades using planktonic cultures (e.g.
[32,33]) and more recently using biofilm cultures [34].
The proposed mechanisms are varied and could involve
complex changes in many cellular systems including
membrane structure, alterations of transmembrane
potential, and the expression of different genes including
multidrug efflux pumps [35-39]. Many of these cellular
properties have been reported to change as a function of
biofilm associated genes including ycfR(bhsA) or as a
function of growth phase based indole secretion [40-42].
Based on the changes in antibiotic tolerance as a func-
tion of glucose, the current data suggests the cAMP-
catabolite repression protein (cAMP-CRP) circuit may
play a role in antibiotic tolerance. Intracellular cAMP lev-
els are widely reported to change in the presence of sug-
ars [43,44]. These effects are often associated with the
PTS sugar transporter systems. Glycerol and gluconate
are not imported via the PTS family of transporters but
both influence the E. coli cAMP-CRP catabolite repres-
sion system through undetermined mechanisms [45,46].
I n t e r e s t i n g l y ,  a u g m e n t i n g  L B  w i t h  g l y c e r o l  m a d e  t h e
wild-type cultures highly sensitive to both kanamycin and
ampicillin. This was not observed with any other supple-
mented carbon source hinting at some unknown aspect
of glycerol metabolism. Adding both glycerol (10 g/L) and
glucose (10 g/L) to the LB resulted in antibiotic tolerance
trends analogous to the LB + glucose medium, consistent
with anticipated glucose repression effects (data not
shown). This would indicate that increased antibiotic
Figure 8 Effect of culturing phase on antibiotic tolerance of wild-
type E. coli K-12 cultures. Cells were grown as biofilms for 6, 12, or 24 
hours prior to being transferred to treatment plates. Cultures treated 
after 6 hours were in late exponential phase while the 12 and 24 hour 
samples were in stationary phase. Reported cfu/biofilm data was de-
termined after treatment. Cultures were grown at 37°C. 8a) LB only me-
dium. 8b) LB and 10 g/L glucose. Black bars = control, dark gray bars = 
kanamycin (100 ug/ml) challenge, light gray bars = ampicillin (100 ug/
ml) challenge. Number at the base of each bar denotes the number of 
independent replicates. cfu = colony forming unit.
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sensitivity in LB + glycerol was not directly due to glyc-
erol permeabilization of the cellular membrane but rather
a metabolic effect.
The cultures grown at 21°C were generally more sus-
ceptible to both kanamycin and ampicillin. At this tem-
perature, there was no observed difference in antibiotic
tolerance as a function of glucose perturbations. The
absence of a nutritional effect suggests the cAMP-CRP
regulatory system is influenced by temperature. Addi-
tional cellular processes could also be contributing to the
observed behaviors including temperature dependent
changes in multidrug pump expression [40], temperature
dependent changes in cellular membrane properties [47]
and temperature dependent changes in growth rate. A
biofilm grown at 21°C for 6 hours would be less estab-
lished than a biofilm grown at 37°C for 6 hours. While
Fig. 8 shows a growth stage dependent change in ampicil-
lin tolerance, it does not show a growth stage dependent
change in kanamycin tolerance when glucose is present.
The changes in antibiotic tolerance at 21°C were for both
kanamycin and ampicillin suggesting it is not just a
growth stage dependent phenomenon.
Interrupting AI-2 QS had varied and unpredictable
effects on antibiotic tolerance. A growing body of
research suggests different organisms use QS for different
purposes and that QS effects can be quite diverse. For
instance, a recent review highlights that the luxS based
AI-2 QS system can increase, decrease, or have no effect
on biofilm formation depending on the organism or
strain [25]. While acylhomoserine lactone (AI-1) based
QS interference has been generally successful with
Pseudomonas aeruginosa [23,48], accessory gene regula-
tor (Agr) based QS interference with Staphylococcus
aureus  and  Staphylococcus epidermidis can make the
microbes more resilient to antibiotic treatments
(reviewed in [49]). The current study demonstrates a
large increase in antibiotic tolerance when the AI-2 QS
system was disrupted however, this effect was gene and
context dependent (Fig. 7). For unknown reasons, the
ΔlsrK strain behaved analogous to the wild-type culture
when perturbed with glucose. The ΔluxS strain was fur-
ther characterized and found not to display a glucose
dependent antibiotic tolerance response (Additional
file1) implying a disruption of a portion of the glucose
repression circuit. The ΔluxS strain did display catabolite
repression based diauxic growth. The strain was grown
on defined M9 medium containing both glucose and
xylose. Like the wild-type strain, the ΔluxS strain prefer-
entially consumed glucose (data not shown). The data
from this study do not support pursuing a strategy of AI-
2 quorum sensing interference as an antifouling approach
with E. coli.
Conclusions
Robustness analysis revealed that colony biofilm antibi-
otic tolerance is very sensitive to culturing perturbations.
These tolerance responses can vary based on single or
aggregate perturbations and are, in many cases, not pre-
dictable. The collective data represents both challenges
and opportunities for the rational design of anti-biofilm
Table 1: Summary of E. coli K-12 biofilm antibiotic tolerance robustness analyses
kanamycin ampicillin
perturbation low LR1 high LR1 ΔLR2 low LR1 high LR1 ΔLR2
glucose 1.3 8.8 7.5 1.5 7.6 6.1
temperature 8.4 9.5 1.1 0.5 5.8 5.3
AI-2 QS 8.8 9.9 1.1 0.3 1.5 1.2
culture stage 1.7 8.8 7.1 0.1 4.6 4.5
glucose + temp. 1.3 9.5 8.2 0.5 7.6 7.1
glucose+AI-2 QS 0.8 9.9 9.1 0.3 7.6 7.3
1. For each set of perturbation data, the lowest and highest log reduction (LR) in cfu's/biofilm are listed. The perturbed conditions are 
compared to biofilm cultures grown on LB only medium at 37°C. cfu = colony forming unit.
2. ΔLR = the maximum observed range in log reductions (LR) between the base scenario and the perturbed culturing condition.Zuroff et al. BMC Microbiology 2010, 10:185
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strategies. The data demonstrates that biofilms can be
countered effectively with some antibiotics if the appro-
priate conditions are applied however, if inappropriate
conditions are applied, the efficacy of the treatment can
be negated. The results indicate it is essential to evaluate
antimicrobial strategies over a range of perturbations rel-
evant to the targeted application so that accurate predic-
tions regarding efficacy can be made.
Methods
Bacterial strains and growth conditions
E. coli K-12 MG1655 gene deletion mutants were con-
structed using the KEIO mutant library and P1 transduc-
tion techniques [50,51]. E. coli cultures were grown in low
salt Luria-Bertani (LB) broth with or without different
substrate supplements. When added, the supplements
were autoclaved separately from the LB medium. The
average starting pH of the medium was 6.8. All antibiotics
were utilized at a final concentration of 100 ug/ml. The
tested antibiotics had different molecular weights so this
mass concentration represents a different molar concen-
tration for each agent. Culturing temperatures ranged
from 21 to 42°C depending on experiment.
Colony biofilm culture antibiotic tolerance testing
The colony biofilm culturing method has been described
previously [3,4,7,52,53]. Briefly, colony biofilm systems
consist of agar plates, sterile 0.22 μm pore- 25 mm diame-
ter polycarbonate membranes (GE Water and Process
Technologies, K02BP02500), and the desired bacterial
strains. The membrane is placed aseptically on agar
plates and inoculated with 100 uL of an exponentially
growing culture (diluted to OD600 = 0.1). The culture is
grown for 6 hours on untreated plates of the desired
medium composition. After the initial growth phase, the
biofilm is aseptically transferred to either a treated or a
control plate where it is incubated for an additional 24
hours. The nutrients and antibiotics enter the biofilm
from below the membrane. Antibiotic penetration of col-
ony biofilms has been studied expensively suggesting the
agent readily moves throughout the biofilm [3]. The
delivery of antibiotic is diffusion based analogous to the
many antibiotic impregnated coating systems. After
treatment, the colony biofilms are aseptically transferred
to 10 ml glass test tubes pre-filled with 5 mL of sterile
phosphate buffered saline. The colony biofilm is vortexed
vigorously for 1 minute to separate the cells from the
membrane. The membrane is removed and discarded.
The dislodged biofilm is homogenized using a tissue
homogenizer for 40 seconds to ensure complete physical
disaggregation. The homogenized culture is serially
diluted and colony forming units (cfu's) per membrane
are enumerated using the drop-plate method [54].
Planktonic culture antibiotic tolerance testing
For planktonic antibiotic tolerance experiments, 50 ml
cultures were grown exponentially for six hours with
shaking (250 ml flask, 150 rpm) at 37°C in untreated
medium (with or without 10 g/L glucose). The cells were
collected using centrifugation (800 rcf, 20 minutes). The
cells were resuspended in fresh medium of noted compo-
sition and cultured for another 24 hours at 37°C with
shaking (150 rpm). The viable cell counts were deter-
mined using serial dilutions and the drop-plate cell enu-
m e r a t i o n  m e t h od  [ 5 4 ] .  A l l  cu l t u r es  w e r e  gr o wn  i n  t h e
presence of atmospheric oxygen.
Deletion mutant generation
E. coli K-12 MG1655 gene deletion mutants were con-
structed using the KEIO knock-out library, P1 transduc-
tion methods, and wild-type E. coli strain MG1655
[50,51]. The strains were verified using PCR and physio-
logical studies.
Statistical analysis of results
Statistical significance was determined using p-values
from unpaired T-tests of experimental and control sam-
ples. All error bars represent standard error of 3 to 8 rep-
licates.
Additional material
Abbreviations
cfu: colony forming unit; QS: quorum sensing; LR: log reduction
Authors' contributions
Conception and design of experiment: TRZ, RPC. Acquisition of data: TRZ, HB,
JLR, LJT. Analysis and interpretation of data: TRZ, PSS, RPC. Drafting the manu-
script: PSS, RPC. Revising the manuscript critically for intellectual content: TRZ,
HB, PSS, RPC. Final approval of published version: TRZ, HB, JLR, LJT, PSS, RPC.
Acknowledgements
The study was funded by NIH grants EB006532 and P20 RR16455-08 from the 
National Center for Research Resources (NCRR).
Author Details
1Department of Chemical and Biological Engineering, Center for Biofilm 
Engineering, Montana State University, Bozeman MT 59717, USA, 2Johns 
Hopkins University, Baltimore Maryland, USA and 3University of Cadiz, Cadiz, 
Spain
References
1. Hoyle BD, Costerton JW: Bacterial resistance to antibiotics: the role of 
biofilms.  Prog Drug Res 1991, 37:91-105.
2. Stewart PS, Costerton JW: Antibiotic resistance of bacteria in biofilms.  
Lancet 2001, 358:135-138.
3. Anderl JN, Franklin MJ, Stewart PS: Role of antibiotic penetration 
limitation in Klebsiella pneumoniae biofilm resistance to ampicillin and 
ciprofloxacin.  Antimicrob Agents Chemother 2000, 44:1818-1824.
Additional file 1 Supplementary culture data. This file contains support-
ing planktonic and biofilm culture.
Received: 28 February 2010 Accepted: 7 July 2010 
Published: 7 July 2010
This article is available from: http://www.biomedcentral.com/1471-2180/10/185 © 2010 Zuroff et al; licensee BioMed Central Ltd.  This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. BMC Microbiology 2010, 10:185Zuroff et al. BMC Microbiology 2010, 10:185
http://www.biomedcentral.com/1471-2180/10/185
Page 9 of 10
4. Anderl JN, Zahller J, Roe R, Stewart PS: Role of nutrient limitation and 
stationary-phase existence in Klebsiella pneumonia biofilm resistance 
to Ampicillin and Ciprofloxacin.  Antimicrob Agents Chemother 2003, 
47:1251-1256.
5. Dhar N, McKinney JD: Microbial phenotypic heterogeneity and 
antibiotic tolerance.  Curr Opin Microbiol 2007, 10:30-38.
6. Levin BR, Rozen DE: Opinion - Non-inherited antibiotic resistance.  Nat 
Rev Microbiol 2006, 4:556-562.
7. Zheng Z, Stewart PS: Growth limitation of Staphylococcus epidermidis in 
biofilms contributes to rifampin tolerance.  Biofilms 2004, 1:31-35.
8. Mermel LA: Prevention of intravenous catheter-related infections.  Ann 
Intern Med 2000, 132:391-402.
9. Veenstra DL, Saint S, Saha S, Lumley T, Sullivan SD: Efficacy of antiseptic-
impregnated central venous catheters in preventing catheter-related 
bloodstream infection.  J Am Med Assoc 1999, 281:261-267.
10. McConnel SA, Gubbins PO, Anaissie EJ: Are antimicrobial-impregnated 
catheters effective? Replace the water and grab your washcloth, 
because we have a baby to wash.  Clin Infect Dis 2004, 39:1829-1833.
11. McConnel SA, Gubbins PO, Anaissie EJ: Do antimicrobial-impregnated 
central venous catheters prevent catheter-related bloodstream 
infection?  Clin Infect Dis 2003, 37:65-72.
12. Crnich CJ, Maki DG: Are antimicrobial impregnated catheters effective? 
When does repetition reach the point of exhaustion?  Clin Infect Dis 
2005, 41:681-685.
13. Mah TF, Pitts B, Pellock B, Walker GC, Stewart PS, O'Toole GA: A genetic 
basis for Pseudomonas aeruginosa biofilm antibiotic resistance.  Nature 
2003, 426:306-310.
14. Dietrich LE, Teal TK, Price-Whelan A, Newman DK: Redox-active 
antibiotics control gene expression and community behavior in 
divergent bacteria.  Science 2008, 321:1203-1206.
15. Rani SA, Pitts B, Beyenal H, Veluchamy RA, Lewandowski Z, Davison WM, 
Buckingham-Meyer K, Stewart PS: Spatial patterns of DNA replication, 
protein synthesis, and oxygen concentration within bacterial biofilms 
reveal diverse physiological states.  J Bacteriol 2007, 189:4223-4233.
16. Kim J, Park HJ, Lee JH, Hahn JS, Gu MB, Yoon J: Differential effect of 
chlorine on the oxidative stress generation in dormant and active cells 
within colony biofilm.  Water Res 2009, 43:5252-5259.
17. Félix M, Wagner A: Robustness and evolution: concepts, insights, and 
challenges from a developmental model system.  Heredity 2008, 
100:132-140.
18. Barkai N, Shilo BZ: Variability and robustness in biomolecular systems.  
Mol Cell 2007, 28:755-760.
19. Udekwu KI, Parrish N, Ankomah P, Baquero F, Levin BR: Functional 
relationship between bacterial cell density and the efficacy of 
antibiotics.  J Antimicrob Chemother 2009, 63:745-757.
20. Sezonov G, Joseleau-Petit D, D'Ari R: Escherichia coli physiology in Luria-
Burtani broth.  J Bacteriol 2007, 189:8746-8749.
21. Bjarnsholt T, Givskov M: Quorum-sensing blockade as a strategy for 
enhancing host defences against bacterial pathogens.  Phil Trans R Soc B 
2007, 362:1213-1222.
22. Reading NC, Sperandio V: Quorum sensing: the many languages of 
bacteria.  FEMS Microbiol Lett 2006, 254:1-11.
23. Hentzer M, Wu H, Andersen JB, Riedel K, Rasmussen TB, Bagge N, Kumar N, 
Schembri MA, Song Z, Kristoffersen P, Manefield M, Costerton JW, Molin S, 
Eberl L, Steinberg P, Kjelleberg S, Høiby N, Givskov M: Attenuation of 
Pseudomonas aeruginosa virulence by quorum sensing inhibitors.  
EMBO J 2003, 22:3803-3815.
24. Rasmussen TB, Givskov M: Quorum-sensing inhibitors as anti-
pathogenic drugs.  Int J Med Microbiol 2006, 296:149-161.
25. Hardie KR, Heurlier K: Establishing bacterial communities by 'word of 
mouth': LuxS and autoinducer 2 in biofilm development.  Nat Rev 
Microbiol 2008, 6:635-643.
26. Wang L, Li J, March JC, Valdes JJ, Bentley WE: luxS-Dependent gene 
regulation in Escherichia coli K-12 revealed by genomic expression 
profiling.  J Bacteriol 2005, 187:8350-8360.
27. Wang L, Hashimoto Y, Tsao CY, Valdes JJ, Bentley WE: Cyclic AMP (cAMP) 
and cAMP receptor protein influence both synthesis and uptake of 
extracellular autoinducer 2 in Escherichia coli.  J Bacteriol 2005, 
187:2066-2076.
28. Xavier KB, Bassler BL: Regulation of uptake and processing of the 
quorum-sensing autoinducer AI-2 in Escherichia coli.  J Bacteriol 2005, 
187:238-248.
29. Kaper JB: Pathogenic Escherichia coli.  Int J Med Microbiol 2005, 
295:355-356.
30. Chen HD, Frankel G: Enteropathogenic Escherichia coli: unraveling 
pathogenesis.  FEMS Microbiol Rev 2005, 29:83-98.
31. Salek MM, Jones SM, Martinuzzi RJ: The influence of flow cell geometry 
related shear stresses on the distribution, structure, and susceptibility 
of Pseudomonas aeruginosa 01 biofilms.  Biofouling 2009, 25:711-725.
32. Conrad RS, Wulf RG, Clay DL: Effects of Carbon-Sources on Antibiotic-
Resistance in Pseudomona aeruginosa.  Antimicrob Agents Chemother 
1979, 15:59-66.
33. Ishikawa S, Matsumura Y, Katoh-Kubo K, Tsuchido T: Antibacterial activity 
of surfactants against Escherichia coli cells is influenced by carbon 
source and anaerobiosis.  J Appl Microbiol 2002, 93:302-309.
34. Borriello G, Werner E, Roe F, Kim AM, Ehrlich GD, Stewart PS: Oxygen 
limitation contributes to antibiotic tolerance of Pseudomonas 
aeruginosa in biofilms.  Antimicrob Agents Chemother 2004, 
48:2659-2664.
35. Bryan LE, Kwan S: Roles of ribosomal-binding, membrane-potential, 
and electron-transport in bacterial uptake of streptomycin and 
gentamicin.  Antimicrob Agents Chemother 1983, 23:835-845.
36. Heir E, Sundheim G, Holck AL: The Staphylococcus qacH gene product: a 
new member of the SMR family encoding multidrug resistance.  FEMS 
Microbiol Lett 1998, 163:49-56.
37. Lacroix FJ, Cloeckaert A, Grepinet O, Pinault C, Popoff MY, Waxin H, Pardon 
P: Salmonella typhimurium acrB-like gene: indentification and role in 
resistance to biliary salts and detergents and in murine infection.  FEMS 
Microbiol Lett 1996, 135:161-167.
38. Nishino K, Yamaguchi A: Analysis of a complete library of putative drug 
transporter genes in Escherichia coli.  J Bacteriol 2001, 183:5803-5812.
39. Yang S, Lopez JR, Zechiedrich EL: Quorum sensing and multidrug 
transporters in Escherichia coli.  Proc Natl Acad Sci 2006, 103:2386-2391.
40. Hirakawa H, Inazumi Y, Masaki T, Hirata T, Yamaguchi A: Indole induces 
the expression of multidrug exporter genes in Escherichia coli.  Mol 
Microbiol 2005, 55:1113-1126.
41. Kobayashi A, Hirakawa H, Hirata T, Nishino K, Yamaguchi A: Growth 
phase-dependent expression of drug exporters in Escherichia coli and 
its contribution to drug tolerance.  J Bacteriol 2006, 188:5693-5703.
42. Zhang XS, Garcia-Contreras R, Wood TK: YcfR (BhsA) influences 
Escherichia coli biofilm formation through stress response and surface 
hydrophobicity.  J Bacteriol 2007, 189:3051-3062.
43. Botsford JL: Cyclic nucleotides in prokaryotes.  Microbiol Rev 1981, 
45:620-642.
44. Botsford JL, Harman JG: Cyclic AMP in prokaryotes.  Microbiol Mol Biol Rev 
1992, 56:100-122.
45. Eppler T, Boos W: Glycerol-3-phosphate-mediated repression of malT in 
Escherichia coli does not require metabolism, depends on enzyme 
IIA(Glc) and is mediated by cAMP levels.  Mol Microbiol 1999, 
33:1221-1231.
46. Hogema BM, Arents JC, Bader R, Eijkemans K, Yoshida H, Takahashi H, Aiba 
H, Postma PW: Inducer exclusion in Escherichia coli by non-PTS 
substrates: the role of the PEP to pyruvate ratio in determining the 
phosphorylation state of enzyme IIAGlc.  Mol Microbiol 1998, 30:487-498.
47. Haest CW, de Gier J, van Deenen LL: Changes in the chemical and barrier 
properties of the membrane lipids of E. coli by variation of the 
temperature of growth.  Chem Phys Lipids 1969, 3:413-417.
48. Davies DG, Parsek MR, Pearson JP, Iglewski BH, Costerton JW, Greenberg 
EP: The involvement of cell-to-cell signals in the development of a 
bacterial biofilm.  Science 1998, 280:295-298.
49. Otto M: Quorum-sensing control in Staphylococci - a target for 
antimicrobial drug therapy?  FEMS Microbiol Lett 2004, 241:135-141.
50. Datsenko KA, Wanner BL: One-step inactivation of chromosomal genes 
in Escherichia coli K-12 using PCR products.  Proc Natl Acad Sci USA 2000, 
97:6640-6645.
51. Baba T, Ara T, Hasegawa M, Takai Y, Okumura Y, Baba M, Datsenko KA, 
Tomita M, Wanner BL, Mori H: Construction of Escherichia coli K-12 in-
frame, single-gene knockout mutants: the Keio collection.  Mol Syst Biol 
2006, 2:2006.0008.
52. Walters MC III, Roe F, Bugnicourt A, Franklin MJ, Stewart PS: Contributions 
of antibiotic penetration, oxygen limitation, and low metabolic activity 
to tolerance of Pseudomonas aeruginosa biofilms to ciprofloxacin and 
tobramycin.  Antimicrob Agents Chemother 2003, 47:317-323.Zuroff et al. BMC Microbiology 2010, 10:185
http://www.biomedcentral.com/1471-2180/10/185
Page 10 of 10
53. Hamilton M: The Biofilm Laboratory Step-By-Step Protocols for 
Experimental Design, Analysis, and Data Interpretation.  Edited by: 
Hamilton M, Heersink J, Buckingham-Meyer K, Goeres D. Cytergy 
Publishing, Bozeman MT; 2003. 
54. Herigstad B, Hamilton M, Heersink J: How to optimize the drop plate 
method for enumerating bacteria.  J Microbiol Methods 2001, 
44:121-129.
doi: 10.1186/1471-2180-10-185
Cite this article as: Zuroff et al., Robustness analysis of culturing perturba-
tions on Escherichia coli colony biofilm beta-lactam and aminoglycoside anti-
biotic tolerance BMC Microbiology 2010, 10:185